Pfizer EBIT 2010-2024 | PFE

Pfizer EBIT for the quarter ending September 30, 2024 was $4.959B, a 244.58% decline year-over-year.

  • Pfizer 2023 EBIT was 0.222B, a 99.36% decline from 2022.
  • Pfizer 2022 EBIT was 34.944B, a 79.82% increase from 2021.
  • Pfizer 2021 EBIT was 19.433B, a 135.55% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Pfizer EBIT 2010-2024 | PFE

  • Pfizer 2023 EBIT was 0.222B, a 99.36% decline from 2022.
  • Pfizer 2022 EBIT was 34.944B, a 79.82% increase from 2021.
  • Pfizer 2021 EBIT was 19.433B, a 135.55% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Merck (MRK)$255.9B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B